Adverum

Adverum

78
Reputation
High
5 open positions
Last updated Jul 12, 2026
Founded 2004
30 employees
Remote18%
Hybrid54%
On-site29%
Salary shown86%
Avg. listing46d
This month0 new · 0 closed

QC Analyst II/III Reviewer (Contract)

$40–$50/hour
47
Low

Adverum Biotechnologies, Inc., wholly owned subsidiary of Eli Lilly and Company, is a mission-driven clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prev

OtherQc AnalystContractMid
See 2 similar>
2 0 0 1mo ago

Senior Scientist, Downstream Process Development (Contract) - AW

$80–$90/hour
42
Low

Adverum Biotechnologies, Inc., wholly owned subsidiary of Eli Lilly and Company, is a mission-driven clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prev

OtherDevelopmentContractLead
See 2 similar>
6 0 0 2mo ago
AdverumAdverum·United StatesUnited States·Redwood City·Remote · United States

Clinical Scientist/Senior (Contract)

$70–$80/hour
51
Low

Adverum Biotechnologies, Inc., wholly owned subsidiary of Eli Lilly and Company, is looking to bring on board a Clinical Scientist/Senior (Contract). This role will support the assigned Clinical Trial Lead with the design and execution of key elements of the Clinical Development Plan (clinical study

OtherHealthcareClinical ScientistContractSenior
See 3 similar>
7 0 0 4mo ago

Director, QA Systems (Contract)

32
Lowest

Adverum Biotechnologies, Inc., a wholly owned subsidiary of Eli Lilly and Company is a mission-driven clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and pre

OtherDirectorContractExecutive
See 2 similar>
0 0 0 4mo ago

Work with us!

$0–$0/hour
44
Low

Adverum is a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prevent blindness. Leveraging the capabilities of its proprietary intravitreal platform, Adv

OtherWork With UsFull TimeMid
See 2 similar>
8 0 0 69mo ago